Philadelphia Attorneys New Jersey Attorneys Pennsylvania Lawyers Golomb & Honik P.C.

Actos Attorneys

Philadelphia, Pennsylvania, New Jersey, Nationwide

In 1999, the Food and Drug Administration first approved the drug Actos to help diabetic patients control their type II diabetes. Since then, it has been prescribed to millions of patients across the United States and has become the leading drug used in the treatment of type II diabetes. In 2010 alone, more than 2.3 million Americans filled prescriptions for this popular drug.

Generically known as pioglitazone, this oral diabetes drug is manufactured by Takeda Pharmaceutical Company and Eli Lilly and has become one of their best sellers. In 2011, the wildly popular drug reached sales of $4.5 billion.

Sadly, these profits came at a steep price—for the consumer. Increasing evidence links the use of Actos to a heightened risk for bladder cancer. So much so, that the FDA warned the public that the use of Actos for more than one year could be associated with an increased risk of developing bladder cancer. Even more disheartening, is that Takeda Pharmaceuticals delayed adding this warning to their products until the FDA required it—while they continued to rake in billions. When pharmaceutical companies routinely put profits before patient safety—the results are disastrous.

The Philadelphia dangerous drug attorneys at Golomb & Honik are actively investigating claims from diabetics who developed bladder cancer after using Actos. At particularly high risk are patients who used Actos for 12 months or longer. If you or someone you love has suffered complications or been diagnosed with bladder cancer after using Actos, call us at 1-800-355-3300 or 1-215-985-9177 immediately to evaluate your case.

The Risks of Actos

Intended to help people with type 2 diabetes control blood-sugar levels, Actos increases insulin sensitivity, thereby encouraging sugar to diffuse from the blood to the body instead of building up in the blood. In the years following the FDA’s approval of Actos, reports of Actos users suffering from bladder cancer began to mount.

In 2011, the FDA determined there was a significant risk of bladder cancer associated with long-term use of Actos and required Actos manufacturer Takeda Pharmaceuticals to issue a new warning with the drug’s packaging that states diabetics who use Actos for longer than 12 months face an increased risk of bladder cancer. Actos has also been linked to a heightened risk for heart failure and diabetic macular edema.

The FDA based their decision to require warning labels on Actos medications after the results of a 10-year Actos study were released. The study found that there was a 40% greater chance of developing bladder cancer after using Actos for longer than a year. In addition, other countries, such as France and Germany, had already suspended the use of Actos and begun recommending new patients not start using the dangerous drug.

Symptoms of Bladder Cancer

Typically, bladder cancer can be treated if diagnosed in its early stages; however, bladder cancer also has a high rate of recurrence and can be fatal. Symptoms of bladder cancer include:

  • Abdominal pain
  • Back pain
  • Bloody urine
  • Frequent urination
  • Painful urination
  • Urinary tract infection

Following its latest review of Actos-related data, the FDA advised doctors not to prescribe the medication to patients also being treated for bladder cancer and not to prescribe the higher dose of Actos to new patients.

If you developed bladder cancer after using the prescription drug Actos to help control your diabetes, please contact the Philadelphia dangerous drug attorneys at Golomb & Honik for your no cost case evaluation. We welcome clients from Pennsylvania, New Jersey and across the United States.

National Actos Lawyers

If you or someone you love has been diagnosed with bladder cancer after using the dangerous drug Actos, you may be able to file a lawsuit. Diabetics who have been injured after taking Actos are currently filing lawsuits across the country. To learn more about your rights and legal options, call the Philadelphia dangerous drug lawyers at Golomb & Honik today at 1-800-355-3300 or 1-215-985-9177 or fill out our confidential Contact Form.

The national dangerous drug lawyers at Golomb & Honik have successfully represented individuals throughout the United States in their quest for justice.

Golomb & Honik

215.985.9177 | 855.889.5389

1515 Market Street , Suite 1100 Philadelphia, PA 19102